Priority Review “Vouchers” Offered To Firms Developing HIV Drugs In FDA Bill
Executive Summary
The Senate's version of FDA user fee reauthorization legislation includes a provision designed to encourage creation of products that treat HIV and other diseases affecting developing countries
You may also be interested in...
NIH Public/Private Partner Grants Highlighted At BIO/Gates Forum
The National Institute of Health's initiative to provide grants to public/private partnerships for early-stage research marks one of several collaborative efforts to advance tropical disease and HIV compounds, NIAID Director Anthony Fauci said March 12
NIH Public/Private Partner Grants Highlighted At BIO/Gates Forum
The National Institute of Health's initiative to provide grants to public/private partnerships for early-stage research marks one of several collaborative efforts to advance tropical disease and HIV compounds, NIAID Director Anthony Fauci said March 12
Wyeth, GSK Vaccines May Get Sales Boost Under Pilot For Developing Countries
Pediatric pneumococcal vaccines in development by Wyeth and GlaxoSmithKline could be the first products to benefit from a pilot program designed to create an incentive to develop vaccines that treat the diseases of the developing world